BCM
NTNX icon

Bayesian Capital Management’s Nutanix NTNX Stock Holding History

Bayesian Capital Management’s Portfolio NTNX Stock Details NTNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-55,400
Closed -$3.87M – 769
2025
Q1 		$3.87M Buy
+55,400
New +$3.83M 0.64% 29
2024
Q4 		– Sell
-46,800
Closed -$2.77M – 888
2024
Q3 		$2.77M Buy
+46,800
New +$2.57M 0.32% 79
2023
Q4 		– Sell
-68,387
Closed -$2.39M – 946
2023
Q3 		$2.39M Buy
68,387
+51,400
+303% +$1.61M 0.27% 92
2023
Q2 		$476K Buy
+16,987
New +$451K 0.05% 420
2023
Q1 		– Sell
-36,587
Closed -$953K – 1000
2022
Q4 		$953K Sell
36,587
-5,900
-14% -$161K 0.14% 193
2022
Q3 		$885K Buy
+42,487
New +$775K 0.18% 153
2022
Q2 		– Sell
-32,400
Closed -$869K – 986
2022
Q1 		$869K Buy
32,400
+23,100
+248% +$619K 0.13% 237
2021
Q4 		$296K Sell
9,300
-12,500
-57% -$429K 0.09% 254
2021
Q3 		$822K Sell
21,800
-1,100
-5% -$41.6K 0.24% 111
2021
Q2 		$875K Sell
22,900
-15,000
-40% -$467K 0.23% 114
2021
Q1 		$1.01M Buy
+37,900
New +$1.15M 0.23% 120
2020
Q4 		– Sell
-35,040
Closed -$777K – 611
2020
Q3 		$777K Buy
+35,040
New +$801K 0.19% 145
2020
Q2 		– Sell
-36,700
Closed -$580K – 694
2020
Q1 		$580K Sell
36,700
-85,700
-70% -$2.41M 0.13% 253
2019
Q4 		$3.83M Buy
+122,400
New +$3.61M 0.65% 19
2018
Q3 		– Sell
-7,883
Closed -$407K – 750
2018
Q2 		$407K Sell
7,883
-15,689
-67% -$862K 0.09% 316
2018
Q1 		$1.16M Sell
23,572
-21,828
-48% -$866K 0.29% 95
2017
Q4 		$1.6M Buy
45,400
+16,300
+56% +$494K 0.33% 76
2017
Q3 		$652K Buy
29,100
+11,600
+66% +$254K 0.16% 213
2017
Q2 		$353K Buy
+17,500
New +$305K 0.13% 241

Other funds holding NTNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bayesian Capital Management's NTNX Position: Q2 2025 in Review

Bayesian Capital Management sold out of Nutanix (NTNX) in Q2 2025, closing a stake of 55,400 shares — an estimated $3.87M sold.

Bayesian Capital Management first reported a position in NTNX in Q2 2017 and held it in 19 quarters. The position peaked at $3.87M in Q1 2025. 615 funds tracked by Wall St. Rank hold NTNX as of Q2 2025.

  • Bayesian Capital Management reported no remaining Nutanix position as of Q2 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 55,400 Nutanix shares in Q2 2025, an estimated $3.87M.
  • Bayesian Capital Management first reported a position in Nutanix in Q2 2017 and held it in 19 quarters.
  • Bayesian Capital Management's Nutanix position peaked at $3.87M in Q1 2025.
  • 615 funds tracked by Wall St. Rank held Nutanix as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.